SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011870
Filing Date
2018-05-08
Accepted
2018-05-08 16:31:56
Documents
63
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20180331.htm 10-Q 1741356
2 EX-10.2 myok-ex102_249.htm EX-10.2 29243
3 EX-31.1 myok-ex311_7.htm EX-31.1 15754
4 EX-31.2 myok-ex312_8.htm EX-31.2 15838
5 EX-32.1 myok-ex321_6.htm EX-32.1 8811
6 GRAPHIC g201805081900230782403.jpg GRAPHIC 61326
  Complete submission text file 0001564590-18-011870.txt   6814905

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT myok-20180331.xml EX-101.INS 1707321
8 XBRL TAXONOMY EXTENSION SCHEMA myok-20180331.xsd EX-101.SCH 45154
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20180331_cal.xml EX-101.CAL 37430
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20180331_def.xml EX-101.DEF 115852
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20180331_lab.xml EX-101.LAB 284726
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20180331_pre.xml EX-101.PRE 238774
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 18815127
SIC: 2834 Pharmaceutical Preparations